Mohamed Fullah
YOU?
Author Swipe
View article: Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever
Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever Open
View article: Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever
Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever Open
View article: Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection
Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection Open
The analytical validation presented here contributed to the ReEBOV RDT being the first antigen-based assay to receive FDA and World Health Organization emergency use authorization for this EVD outbreak, in February 2015.
View article: Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies
Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies Open
Lassa fever is a significant health threat to West African human populations with hundreds of thousands of annual cases. There are no approved medical countermeasures currently available. Compassionate use of the antiviral drug ribavirin o…
View article: Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits Open
Lassa fever is a severe multisystem disease that often has haemorrhagic manifestations. The epitopes of the Lassa virus (LASV) surface glycoproteins recognized by naturally infected human hosts have not been identified or characterized. He…